
6/8/2026
DEMENTIA Scientific Breakthrough
A large-scale clinical study reveals that GLP-1 receptor agonists (diabetes/weight-loss drugs) reduce the risk of dementia and Alzheimer's by 35%.
Comprehensive tracking of clinical trial readouts, endpoints, and statistical efficacy metrics.

A large-scale clinical study reveals that GLP-1 receptor agonists (diabetes/weight-loss drugs) reduce the risk of dementia and Alzheimer's by 35%.

A personalized mRNA cancer vaccine tailored to individual tumor mutations prevents pancreatic cancer recurrence by training T-cells.

Brain-computer interface implants translate motor cortex intent into wireless device controls, restoring communication to paralyzed patients.